Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Infinity Pharmaceuticals (INFI)
OTHER OTC:INFI
Infinity Pharma (INFI) Stock Price & Analysis
939 Followers
INFI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.01 - $1.30
Previous Close$0.01
Volume313.58K
Average Volume (3M)3.94M
Market Cap
$1.52M
Enterprise ValueN/A
Total Cash (Recent Filing)$17.70M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)>-0.1
Beta1.76
Next Earnings
Nov 01, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.46
Shares Outstanding90,761,081
10 Day Avg. Volume1,964,965
30 Day Avg. Volume3,937,684
Standard Deviation0.34
R-Squared0.05
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)-0.04
Price to Sales (P/S)1.95
Price to Cash Flow (P/CF)-0.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Infinity Pharma News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
INFI FAQ
What was Infinity Pharmaceuticals’s price range in the past 12 months?
Infinity Pharmaceuticals lowest stock price was $0.01 and its highest was $1.30 in the past 12 months.
What is Infinity Pharmaceuticals’s market cap?
Currently, no data Available
When is Infinity Pharmaceuticals’s upcoming earnings report date?
Infinity Pharmaceuticals’s upcoming earnings report date is Nov 01, 2023 which is in 33 days.
How were Infinity Pharmaceuticals’s earnings last quarter?
Infinity Pharmaceuticals released its earnings results on Aug 08, 2023. The company reported -$0.111 earnings per share for the quarter, beating the consensus estimate of -$0.12 by $0.009.
Is Infinity Pharmaceuticals overvalued?
According to Wall Street analysts Infinity Pharmaceuticals’s price is currently Overvalued.
Does Infinity Pharmaceuticals pay dividends?
Infinity Pharmaceuticals does not currently pay dividends.
What is Infinity Pharmaceuticals’s EPS estimate?
Infinity Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Infinity Pharmaceuticals have?
Infinity Pharmaceuticals has 90,761,080 shares outstanding.
What happened to Infinity Pharmaceuticals’s price movement after its last earnings report?
Infinity Pharmaceuticals reported an EPS of -$0.111 in its last earnings report, beating expectations of -$0.12. Following the earnings report the stock price went up 44.444%.
Which hedge fund is a major shareholder of Infinity Pharmaceuticals?
Among the largest hedge funds holding Infinity Pharmaceuticals’s share is Carlson Capital LP. It holds Infinity Pharmaceuticals’s shares valued at 273K.
---
Infinity Pharma Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Increased
By 300.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▲ 0.8%
Last 30 Days ▲ 0.1%
Last 30 Days ▲ 0.1%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-98.63%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-65.68%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Infinity Pharmaceuticals
Infinity Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in discovering, developing and delivering medicines for people with cancer. It focuses on drug development. The company was founded by Steven H. Holtzman on March 22, 1995 and is headquartered in Cambridge, MA.
---
Top 5 ETFs holding INFI
Vanguard Total Stock Market ETF
$232.63K
Up to five ETFs with an Outperform Smart Score that hold INFI. The ETFs are listed according to market value of INFI within the ETF
---